Insider Trading activities of Boston Scientific Corp insiders. , Part 8

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Boston Scientific Corp since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Boston Scientific Corp since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Boston Scientific Corp since 2005. The reporting company's ticker symbol is BSX. The reporting company's CIK number is 885725.
The total value of stock buying since 2005 is $23,762,101.
The total value of stock sales since 2005 is $881,921,170.
The total value of stock option exercises since 2005 is $81,857,292.



Table 2. Detailed insider stock purchases, sales, and option exercises of Boston Scientific Corp insiders (BSX) , Part 8
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2010-04-14 Abele John E (Director) Sale 75,000 7.09 531,750
2010-04-13 Nicholas Peter M (Director) Sale 25,000 6.91 172,725
2010-04-13 Abele John E (Director) Sale 75,000 6.91 518,025
2010-04-12 Nicholas Peter M (Director) Sale 25,000 7.02 175,450
2010-04-12 Abele John E (Director) Sale 75,000 7.01 526,125
2010-04-09 Nicholas Peter M (Director) Sale 25,000 6.95 173,725
2010-04-09 Abele John E (Director) Sale 75,000 6.95 520,950
2010-04-08 Nicholas Peter M (Director) Sale 25,000 7.04 176,000
2010-04-08 Abele John E (Director) Sale 75,000 7.04 527,850
2010-04-07 Nicholas Peter M (Director) Sale 25,000 7.11 177,800
2010-04-07 Abele John E (Director) Sale 75,000 7.11 533,175
2010-04-06 Nicholas Peter M (Director) Sale 25,000 7.15 178,700
2010-04-06 Abele John E (Director) Sale 75,000 7.15 536,100
2010-04-05 Nicholas Peter M (Director) Sale 25,000 7.20 180,025
2010-04-05 Abele John E (Director) Sale 75,000 7.20 539,850
2010-04-01 Nicholas Peter M (Director) Sale 25,000 7.22 180,475
2010-04-01 Abele John E (Director) Sale 75,000 7.22 541,200
2010-03-31 Nicholas Peter M (Director) Sale 25,000 7.21 180,325
2010-03-31 Abele John E (Director) Sale 75,000 7.21 540,900
2010-03-30 Nicholas Peter M (Director) Sale 25,000 7.14 178,600
2010-03-30 Abele John E (Director) Sale 75,000 7.14 535,350
2010-03-29 Nicholas Peter M (Director) Sale 25,000 7.05 176,350
2010-03-29 Abele John E (Director) Sale 75,000 7.05 528,525
2010-03-26 Nicholas Peter M (Director) Sale 25,000 6.98 174,525
2010-03-26 Abele John E (Director) Sale 75,000 6.98 523,275
2010-03-25 Nicholas Peter M (Director) Sale 25,000 6.97 174,350
2010-03-25 Abele John E (Director) Sale 75,000 6.97 522,900
2010-03-24 Nicholas Peter M (Director) Sale 25,000 7.04 175,975
2010-03-24 Abele John E (Director) Sale 75,000 7.04 527,625
2010-03-23 Nicholas Peter M (Director) Sale 25,000 6.95 173,625
2010-03-23 Abele John E (Director) Sale 75,000 6.92 518,850
2010-03-22 Nicholas Peter M (Director) Sale 25,000 7.01 175,300
2010-03-22 Abele John E (Director) Sale 75,000 7.03 527,175
2010-03-19 Nicholas Peter M (Director) Sale 25,000 7.12 178,125
2010-03-19 Abele John E (Director) Sale 75,000 7.12 534,375
2010-03-18 Nicholas Peter M (Director) Sale 25,000 6.90 172,600
2010-03-18 Abele John E (Director) Sale 75,000 6.92 519,000
2010-03-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Sale 2,963 6.40 18,963
2010-03-15 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 2,963 6.12 18,148
2010-03-01 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 3,375 .00 0
2010-02-24 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 1,326 .00 0
2010-02-24 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 1,326 .00 0
2010-02-24 Phalen Michael P. (SVP & President, Endoscopy) Option Ex 4,699 .00 0
2010-02-24 Lance Jean Fitterer (SVP & Chief Compliance Officer) Option Ex 3,012 .00 0
2010-02-24 Pratt Timothy A. (EVP, GC & Chief Admin Officer) Option Ex 3,012 .00 0
2010-02-24 Kucheman William (EVP, Cardiology) Option Ex 3,012 .00 0
2010-02-24 Pucel Kenneth (EVP, Global Operations) Option Ex 3,012 .00 0
2010-02-24 Burns Brian R (SVP - Global Quality) Option Ex 3,615 .00 0
2010-02-24 Gilbert James (EVP, Strategy & Business Dev) Option Ex 3,314 .00 0
2010-02-24 Leno Sam R (CFO & EVP Finance & IS) Option Ex 6,024 .00 0
2010-02-24 Capello Jeffrey D (SVP, Chief Accounting Officer) Option Ex 3,012 .00 0
2010-02-24 Colen Fred (EVP & Chief Technology Officer) Option Ex 3,012 .00 0
2010-02-16 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 2,920 .00 0
2010-02-16 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 1,635 .00 0
2010-02-12 Fitzgerald Joseph Michael (SVP & President, Endovascular) Option Ex 1,996 .00 0
2010-02-12 Pedersen John B. (Pres, Uro & Women's Health) Option Ex 998 .00 0
2010-02-12 Phalen Michael P. (SVP & President, Endoscopy) Option Ex 3,274 .00 0
2010-02-12 Lance Jean Fitterer (Chief Compliance Officer) Option Ex 3,194 .00 0
2010-02-12 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 3,993 .00 0
2010-02-12 Mcfaul David W (SVP, International) Option Ex 2,795 .00 0
2010-02-12 Kucheman William (EVP, Cardiology) Option Ex 7,986 .00 0
2010-02-12 Pucel Kenneth (EVP, Global Operations) Option Ex 13,178 .00 0
2010-02-12 Burns Brian R (SVP - Global Quality) Option Ex 10,806 .00 0
2010-02-12 Gilbert James (EVP, Strategy & Business Dev) Option Ex 3,993 .00 0
2010-02-12 Leno Sam R (CFO & EVP Finance & IS) Option Ex 10,982 .00 0
2010-02-12 Paul Donovan (SVP, Corporate Communications) Option Ex 10,406 .00 0
2010-02-12 Colen Fred (EVP & Chief Technology Officer) Option Ex 19,468 .00 0
2010-02-12 Moreci Stephen F (SVP, Global Sales Operations) Option Ex 2,995 .00 0
2010-01-04 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 588 .00 0
2009-11-13 Nicholas Peter M (Director) Sale 205,482 8.29 1,702,418
2009-11-12 Nicholas Peter M (Director) Sale 150,000 8.29 1,243,950
2009-11-11 Nicholas Peter M (Director) Sale 150,000 8.34 1,251,450
2009-11-10 Nicholas Peter M (Director) Sale 150,000 8.21 1,230,900
2009-11-09 Nicholas Peter M (Director) Sale 200,000 8.19 1,638,800
2009-11-06 Nicholas Peter M (Director) Sale 150,000 8.08 1,212,000
2009-11-05 Nicholas Peter M (Director) Sale 250,000 8.01 2,002,500
2009-11-02 Mcfaul David W (Senior VP International) Option Ex 2,645 .00 0
2009-11-02 Kucheman William (SVP & Group President) Option Ex 6,500 .00 0
2009-11-02 Pucel Kenneth (EVP, Operations) Option Ex 6,500 .00 0
2009-10-30 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,290 .00 0
2009-10-30 Mcfaul David W (Senior VP International) Option Ex 9,332 .00 0
2009-10-29 Nicholas Peter M (Director) Sale 50,000 8.21 410,300
2009-10-29 Abele John E (Director) Sale 125,000 8.23 1,028,624
2009-10-28 Nicholas Peter M (Director) Sale 50,000 8.22 411,050
2009-10-28 Abele John E (Director) Sale 100,000 8.23 823,100
2009-10-27 Nicholas Peter M (Director) Sale 50,000 8.43 421,500
2009-10-27 Abele John E (Director) Sale 100,000 8.44 843,699
2009-10-26 Nicholas Peter M (Director) Sale 50,000 8.50 424,899
2009-10-26 Abele John E (Director) Sale 100,000 8.62 861,800
2009-10-23 Abele John E (Director) Sale 100,000 8.62 861,600
2009-10-22 Abele John E (Director) Sale 50,000 8.40 420,000
2009-10-21 Nicholas Peter M (Director) Sale 100,000 8.35 835,300
2009-10-20 Nicholas Peter M (Director) Sale 100,000 8.98 898,100
2009-10-19 Nicholas Peter M (Director) Sale 100,000 10.19 1,018,800
2009-10-16 Nicholas Peter M (Director) Sale 100,000 10.03 1,003,300
2009-10-15 Nicholas Peter M (Director) Sale 100,000 10.06 1,005,700
2009-10-14 Nicholas Peter M (Director) Sale 100,000 10.03 1,002,699
2009-10-13 Nicholas Peter M (Director) Sale 100,000 9.94 993,600
2009-10-12 Nicholas Peter M (Director) Sale 100,000 10.06 1,005,599
2009-10-09 Nicholas Peter M (Director) Sale 100,000 10.30 1,029,800
2009-10-08 Nicholas Peter M (Director) Sale 100,000 10.31 1,031,100
2009-10-07 Nicholas Peter M (Director) Sale 100,000 10.03 1,003,400
2009-10-06 Nicholas Peter M (Director) Sale 100,000 9.96 995,500
2009-08-20 Kucheman William (SVP & Group President) Sale 11,668 11.20 130,681
2009-08-20 Kucheman William (SVP & Group President) Option Ex 11,668 6.13 71,524
2009-08-11 Elliott John Raymond (President and CEO) Buy 100,000 11.06 1,105,800
2009-07-31 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 3,118 .00 0
2009-07-29 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 4,167 .00 0
2009-07-29 Colen Fred (President, CRM) Option Ex 4,584 .00 0
2009-07-24 Gilbert James (EVP) Option Ex 5,017 .00 0
2009-07-24 Mcconnell William F Jr (SVP, Administration CRM) Option Ex 9,046 .00 0
2009-07-10 Baim Donald S (EVP, Chief Med. & Sci. Officer) Option Ex 16,668 .00 0
2009-07-01 Mcfaul David W (Senior VP International) Option Ex 3,280 .00 0
2009-07-01 Kucheman William (SVP & Group President) Option Ex 4,300 .00 0
2009-07-01 Quinn Lucia Luce (Exec. Vice President-HR) Option Ex 8,000 .00 0
2009-07-01 Pucel Kenneth (EVP, Operations) Option Ex 8,000 .00 0
2009-07-01 Burns Brian R (SVP - Quality) Option Ex 8,000 .00 0
2009-07-01 Gilbert James (EVP) Option Ex 8,000 .00 0
2009-07-01 Paul Donovan (SVP, Corporate Comm) Option Ex 8,000 .00 0
2009-07-01 Colen Fred (President, CRM) Option Ex 8,000 .00 0
2009-07-01 Moreci Stephen F (Sr. VP, Endosurgery) Option Ex 8,000 .00 0
2009-06-20 Mcfaul David W (Senior VP International) Option Ex 4,912 .00 0
2009-06-16 Capello Jeffrey D (SVP, Chief Accounting Officer) Option Ex 29,325 .00 0
2009-06-05 Leno Sam R (CFO & EVP Finance & IS) Option Ex 100,000 .00 0
2009-05-26 Mcconnell William F Jr (SVP, Administration CRM) Sale 23,060 8.87 204,565
2009-05-18 Quinn Lucia Luce (Exec. Vice President-HR) Option Ex 1,375 .00 0
2009-05-18 Gilbert James (EVP) Option Ex 5,450 .00 0
2009-05-18 Paul Donovan (SVP, Corporate Comm) Option Ex 2,200 .00 0
2009-05-18 Abele John E (Director) Sale 100,000 8.64 864,500
2009-05-15 Abele John E (Director) Sale 100,000 8.81 880,800
2009-05-14 Abele John E (Director) Sale 100,000 8.98 898,300
2009-05-13 Abele John E (Director) Sale 100,000 8.80 880,100
2009-05-12 Abele John E (Director) Sale 100,000 9.24 924,100
2009-05-11 Pepper John E (Director) Buy 6,000 9.18 55,080
2009-05-11 Abele John E (Director) Sale 100,000 9.14 914,500
2009-05-08 Mcfaul David W (Senior VP International) Option Ex 875 .00 0
2009-05-08 Mcconnell William F Jr (SVP, Administration CRM) Option Ex 18,575 .00 0
2009-05-08 Colen Fred (President, CRM) Option Ex 11,375 .00 0
2009-05-08 Abele John E (Director) Sale 100,000 9.23 923,400
2009-05-07 Onuscheck John Michael (SVP & Pres-Neuromodulation) Option Ex 2,350 .00 0
2009-05-07 Gilbert James (EVP) Option Ex 7,798 .00 0
2009-05-07 Abele John E (Director) Sale 100,000 8.85 884,500
2009-05-06 Pepper John E (Director) Buy 6,000 8.60 51,600
2009-05-06 Mario Ernest (Director) Buy 50,000 8.49 424,650
2009-05-06 Abele John E (Director) Sale 100,000 8.48 848,100
2009-05-05 Abele John E (Director) Sale 100,000 8.50 850,300
2009-05-01 Pratt Timothy A. (EVP & General Counsel) Option Ex 14,750 .00 0
2009-04-22 Abele John E (Director) Sale 150,000 8.64 1,296,600
2009-04-21 Abele John E (Director) Sale 150,000 8.46 1,269,600
2009-04-20 Abele John E (Director) Sale 150,000 8.76 1,313,250

Insider trading activities including stock purchases, stock sales, and option exercises of BSX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Boston Scientific Corp (symbol BSX, CIK number 885725) see the Securities and Exchange Commission (SEC) website.